{"SPADE_UN_16243": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16243", "Peptide Name": "Apidaecin-1B [R4K, I8R]", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GNNKPVYRPQPRPPHPRL", "Sequence Length": 18, "UniProt Entry": ["http://www.uniprot.org/uniprot/P35581"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A431 (30% Cytotoxicity=10 µM); MDA-MB-231 (Not active up to 10 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C95H151N33O23", "Mass": 2123.42, "PI": 11.72, "Net Charge": 5, "Hydrophobicity": -1.91, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery", "Pubmed ID": "31209863", "Reference": "Biotechnol Bioeng. 2019 Oct;116(10)2439-2450.", "Author": "Lai PK, Tresnak DT, Hackel BJ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31209863"}], "Frequent Amino Acids": "PRN", "Absent Amino Acids": "ACDEFIMOSTUW", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 10, "Positive Residues": 5, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13344", "Similarity": 1.0, "Sequence": "GNNPVYPQPRPPPR"}, {"SPADE_ID": "SPADE_UN_23792", "Similarity": 1.0, "Sequence": "KYYGNGVHCGKHSCTVDWGTAIGNIGNNAAANWATGGNAGNNK"}, {"SPADE_ID": "SPADE_N_15546", "Similarity": 1.0, "Sequence": "NKPRPQQVPPRPPHPRL"}]}}}